All lobbying filings
MEHLMAN CONSULTING, INC.
MEHLMAN CONSULTING, INC. filed a Q2 report for ASSOCIATION OF ACCESSIBLE MEDICINES on July 21, 2025, reporting $60,000 in lobbying income.
Lobbying for ASSOCIATION OF ACCESSIBLE MEDICINES · Trade Association
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$60,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
1
-
JON ADAME New on this filingPreviously held: CoS, LD, GC (Sen. Blackburn); Counsel (Rep. Blackburn); Policy Coordinator (House E&C); Intern (Sen. Domenici)
Government bodies contacted
2
Lobbying activity
3
Issues related to generic medicines.
Issues related to generic medicines. issues related to generic and biosimilar medications.
Issues related to pharmaceutical manufacturing supply chain. S. 1040 - Drug Competition Enhancement Act. S. 1954 - Biosimilar Red Tape Elimination Act. H.R. 3269 - ETHIC Act.